Thermal ablation for cervical precancerous lesions
Cervical intraepithelial neoplasia (CIN), also called cervical dysplasia, is an abnormal growth of cells on the surface of the cervix.
It is diagnosed histologically as CIN1, CIN2, or CIN3. CIN2+ is caused by chronic infection of the cervix with HPV, particularly high-risk HPV types 16 or 18. Like other intraepithelial neoplasms, CIN is not cancer and is usually curable. However, in a small percentage of cases, cervical cancer develops if left untreated, usually squamous cell carcinoma of the cervix (SCC).
For outpatient treatment of CIN2+
The C3 is a treatment device for C2+ lesions for the outpatient setting. It is designed for use in low-resource environments. It can be operated independently of a power grid and clinical infrastructure, is mobile and easy to use. It offers ease of use combined with the same high efficacy as the previous gold standard (cryotherapy).
6001 PORTIO COAGULATOR
For clinical treatment of CIN2+ and Haemostasis after
LEEP / LLETZ
The 6001 is a treatment device for C2+ lesions for clinical use. Due to the variety of different probes and the variable setting range of the application temperature, this device allows a broader application than the C3. However, the device requires a power supply to operate, the probes are recyclable and must be autoclaved after each use.
– Selection of different therapy probes
– Gasless treatment
– Short application time
– Low operating costs